184 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 4 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MT1BMetallothionein 1BGroup enriched
MTTPMicrosomal triglyceride transfer proteinDisease related genes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MUC13Mucin 13, cell surface associatedPredicted membrane proteins
Predicted secreted proteins
Group enriched
MUC17Mucin 17, cell surface associatedCancer-related genes
Predicted membrane proteins
Predicted secreted proteins
Group enriched
MUC2Mucin 2, oligomeric mucus/gel-formingPlasma proteins
Predicted secreted proteins
Group enriched
MUC3AMucin 3A, cell surface associatedPredicted membrane proteins
Group enriched
MUC6Mucin 6, oligomeric mucus/gel-formingPredicted secreted proteins
Group enriched
MYO1AMyosin IADisease related genes
Plasma proteins
Group enriched
MYRFLMyelin regulatory factor-likeEnzymes
Predicted membrane proteins
Predicted secreted proteins
Group enriched
NAT2N-acetyltransferase 2 (arylamine N-acetyltransferase)Cancer-related genes
Enzymes
Group enriched
NEUROD1Neuronal differentiation 1Disease related genes
Transcription factors
Group enriched
NKX6-3NK6 homeobox 3Transcription factors
Group enriched
NLRP6NLR family, pyrin domain containing 6Plasma proteins
Group enriched
NOS2Nitric oxide synthase 2, inducibleCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Group enriched
NPC1L1NPC1-like 1FDA approved drug targets
Predicted membrane proteins
Group enriched
NR1I2Nuclear receptor subfamily 1, group I, member 2FDA approved drug targets
Nuclear receptors
Plasma proteins
Transcription factors
Group enriched
OTCOrnithine carbamoyltransferaseDisease related genes
Enzymes
Mitochondrial proteins
Plasma proteins
Potential drug targets
Group enriched
PCK2Phosphoenolpyruvate carboxykinase 2 (mitochondrial)Citric acid cycle related proteins
Disease related genes
Enzymes
Mitochondrial proteins
Plasma proteins
Potential drug targets
Group enriched
PIGRPolymeric immunoglobulin receptorCancer-related genes
Plasma proteins
Predicted membrane proteins
Group enriched
PLA2G12BPhospholipase A2, group XIIBPlasma proteins
Predicted secreted proteins
RAS pathway related proteins
Group enriched
PLCB3Phospholipase C, beta 3 (phosphatidylinositol-specific)Enzymes
Group enriched
PPP1R14DProtein phosphatase 1, regulatory (inhibitor) subunit 14DGroup enriched
PRAP1Proline-rich acidic protein 1Predicted secreted proteins
Group enriched
RBP2Retinol binding protein 2, cellularTransporters
Group enriched
REG1ARegenerating islet-derived 1 alphaPlasma proteins
Predicted secreted proteins
Group enriched
REG3ARegenerating islet-derived 3 alphaPlasma proteins
Predicted secreted proteins
Transporters
Group enriched
REG4Regenerating islet-derived family, member 4Predicted secreted proteins
Group enriched
REP15RAB15 effector proteinGroup enriched
RP11-595B24.2Uncharacterized protein Group enriched
RP11-77K12.7Group enriched
SHDSrc homology 2 domain containing transforming protein DGroup enriched
SISucrase-isomaltase (alpha-glucosidase)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
SLC10A2Solute carrier family 10 (sodium/bile acid cotransporter), member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
SLC13A2Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2Predicted membrane proteins
Transporters
Group enriched
SLC15A1Solute carrier family 15 (oligopeptide transporter), member 1Predicted membrane proteins
Transporters
Group enriched
SLC17A4Solute carrier family 17, member 4Predicted membrane proteins
Transporters
Group enriched
SLC23A3Solute carrier family 23, member 3Predicted membrane proteins
Predicted secreted proteins
Transporters
Group enriched
SLC26A3Solute carrier family 26 (anion exchanger), member 3Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
SLC28A1Solute carrier family 28 (concentrative nucleoside transporter), member 1Predicted membrane proteins
Transporters
Group enriched
SLC2A7Solute carrier family 2 (facilitated glucose transporter), member 7Predicted membrane proteins
Transporters
Group enriched
SLC35G1Solute carrier family 35, member G1Predicted membrane proteins
Transporters
Group enriched
SLC39A5Solute carrier family 39 (zinc transporter), member 5Predicted membrane proteins
Predicted secreted proteins
Transporters
Group enriched
SLC52A1Solute carrier family 52 (riboflavin transporter), member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
SLC5A1Solute carrier family 5 (sodium/glucose cotransporter), member 1Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
SLC5A11Solute carrier family 5 (sodium/inositol cotransporter), member 11Predicted membrane proteins
Group enriched
SLC5A4Solute carrier family 5 (glucose activated ion channel), member 4Predicted membrane proteins
Transporters
Group enriched
SLC5A9Solute carrier family 5 (sodium/sugar cotransporter), member 9Predicted membrane proteins
Transporters
Group enriched
SLC6A19Solute carrier family 6 (neutral amino acid transporter), member 19Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
SLC6A4Solute carrier family 6 (neurotransmitter transporter), member 4FDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
SLC7A9Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched

« prev | Page of 4 | next »